Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibudilast for ME/CFS patients with PET-evidenced neuroinflammation
jRCTs051190067Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ibudilast in myalgic encephalomyelitis (ME), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Safety evaluation. Started Oct 2019; status: completed.
02
Drugs
ibudilast
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on jRCTs051190067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190067.